BSV portfolio can touch Rs 5K cr in 3-4 yrs: Mankind Pharma's Rajeev Juneja
'We don't want to get into exports with generic or me-too products. We always wanted products with a high level of entry barriers and complexity'
'We don't want to get into exports with generic or me-too products. We always wanted products with a high level of entry barriers and complexity'